Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Òscar Miró, Bernardino González de la Presa, Pablo Herrero-Puente, Rosa Fernández Bonifacio, Martin Möckel, Christian Mueller, Gregori Casals, Silvia Sandalinas, Pere Llorens, Francisco Javier Martín-Sánchez, Javier Jacob, José Luis Bedini & Víctor Gil. (2017) The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure. Biomarkers 22:8, pages 731-739.
Read now
Read now
Simon Maltais, Steven J Joggerst, Antonis Hatzopoulos, Thomas G DiSalvo, David Zhao, Hak-Joon Sung, Xintong Wang, John G Byrne & Allen J Naftilan. (2013) Stem cell therapy for chronic heart failure: an updated appraisal. Expert Opinion on Biological Therapy 13:4, pages 503-516.
Read now
Read now
Articles from other publishers (39)
Shahanaz parveen Shaik, Hasnain hyder Karan, Arkaja Singh, Sai kiran Attuluri, Afnan Akram Nawaz Khan, Fazila Zahid & Dhrumil Patil. (2024) HFpEF: New biomarkers and their diagnostic and prognostic value. Current Problems in Cardiology 49:1, pages 102155.
Crossref
Crossref
Beata Zaborska, Małgorzata Sikora-Frąc, Krzysztof Smarż, Ewa Pilichowska-Paszkiet, Andrzej Budaj, Dariusz Sitkiewicz & Grażyna Sygitowicz. (2023) The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?. International Journal of Molecular Sciences 24:17, pages 13111.
Crossref
Crossref
Kristen Coletti, Megan Griffiths, Melanie Nies, Stephanie Brandal, Allen D. Everett & Melania M. Bembea. (2022) Cardiac Dysfunction Biomarkers Are Associated With Potential for Successful Separation From Extracorporeal Membrane Oxygenation in Children. ASAIO Journal 69:2, pages 198-204.
Crossref
Crossref
雅倩 周. (2023) Application and Progress of Biomarkers in Heart Failure. Advances in Clinical Medicine 13:05, pages 7183-7190.
Crossref
Crossref
Grażyna Sygitowicz, Agata Maciejak-Jastrzębska & Dariusz Sitkiewicz. (2021) The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases. Biomolecules 12:1, pages 46.
Crossref
Crossref
Tobias Daniel Trippel, Meinhard Mende, Hans‐Dirk Düngen, Djawid Hashemi, Johannes Petutschnigg, Kathleen Nolte, Christoph Herrmann‐Lingen, Lutz Binder, Gerd Hasenfuss, Burkert Pieske, Rolf Wachter & Frank Edelmann. (2021) The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study. ESC Heart Failure 8:2, pages 829-841.
Crossref
Crossref
Mahmoud U. Sani, Albertino Damasceno, Beth A. Davison, Gad Cotter, Bongani M. Mayosi, Christopher Edwards, Feriel Azibani, Tasneem Adam, Gulnaze Arif, Neusa Jessen & Karen Sliwa. (2020) N‐terminal pro BNP and galectin‐3 are prognostic biomarkers of acute heart failure in sub‐Saharan Africa: lessons from the BAHEF trial. ESC Heart Failure 8:1, pages 74-84.
Crossref
Crossref
Zhan-Qi Cao, Xin Yu & Ping Leng. (2021) Research progress on the role of gal-3 in cardio/cerebrovascular diseases. Biomedicine & Pharmacotherapy 133, pages 111066.
Crossref
Crossref
Yang Liu, Daoxia Guo, Aili Wang, Jingyuan Yang, Zhengbao Zhu, Tan Xu, Chongke Zhong, Hao Peng, Jing Chen, Yafeng Zhou, Yonghong Zhang & Jiang He. (2020) Combined effect of serum N-terminal pro-brain natriuretic peptide and galectin-3 on prognosis 1 year after ischemic stroke. Clinica Chimica Acta 511, pages 33-39.
Crossref
Crossref
Xiaorong Han, Shuai Zhang, Zhongbo Chen, Binay Kumar Adhikari, Ying Zhang, Jin Zhang, Jian Sun & Yonggang Wang. (2020) Cardiac biomarkers of heart failure in chronic kidney disease. Clinica Chimica Acta 510, pages 298-310.
Crossref
Crossref
Leili Pourafkari, Arezou Tajlil & Nader D Nader. (2019) Biomarkers in diagnosing and treatment of acute heart failure. Biomarkers in Medicine 13:14, pages 1235-1249.
Crossref
Crossref
Robert B. Klanderman, Joachim J. Bosboom, Yazan Migdady, Denise P. Veelo, Bart F. Geerts, Michael F. Murphy & Alexander P.J. Vlaar. (2018) Transfusion‐associated circulatory overload—a systematic review of diagnostic biomarkers. Transfusion 59:2, pages 795-805.
Crossref
Crossref
Seonghoon Choi. (2018) Acute Heart Failure and Its Management. Journal of Neurocritical Care 11:1, pages 13-22.
Crossref
Crossref
R. I. Lala, D. Lungeanu, D. Darabantiu, L. Pilat & M. Puschita. (2017) Galectin-3 as a marker for clinical prognosis and cardiac remodeling in acute heart failureGalektin-3 als Marker der klinischen Prognose und des kardialen Remodeling bei akuter Herzinsuffizienz. Herz 43:2, pages 146-155.
Crossref
Crossref
Carolin Gehlken, Navin Suthahar, Wouter C. Meijers & Rudolf A. de Boer. (2018) Galectin-3 in Heart Failure. Heart Failure Clinics 14:1, pages 75-92.
Crossref
Crossref
Hani N. Sabbah. (2017) Pathophysiology of acute heart failure syndrome: a knowledge gap. Heart Failure Reviews 22:6, pages 621-639.
Crossref
Crossref
Clyde W. Yancy, Mariell Jessup, Biykem BozkurtJaved ButlerDonald E. CaseyJrJrMonica M. ColvinMark H. DraznerGerasimos S. FilippatosGregg C. FonarowMichael M. GivertzSteven M. HollenbergJoAnn LindenfeldFrederick A. MasoudiPatrick E. McBridePamela N. PetersonLynne Warner StevensonCheryl Westlake. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 136:6.
Crossref
Crossref
Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. CaseyJr.Jr., Monica M. Colvin, Mark H. Drazner, Gerasimos S. Filippatos, Gregg C. Fonarow, Michael M. Givertz, Steven M. Hollenberg, JoAnn Lindenfeld, Frederick A. Masoudi, Patrick E. McBride, Pamela N. Peterson, Lynne Warner Stevenson & Cheryl Westlake. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology 70:6, pages 776-803.
Crossref
Crossref
Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. CaseyJr.Jr., Monica M. Colvin, Mark H. Drazner, Gerasimos S. Filippatos, Gregg C. Fonarow, Michael M. Givertz, Steven M. Hollenberg, JoAnn Lindenfeld, Frederick A. Masoudi, Patrick E. McBride, Pamela N. Peterson, Lynne Warner Stevenson & Cheryl Westlake. (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. Journal of Cardiac Failure 23:8, pages 628-651.
Crossref
Crossref
Chao-Hung Wang, Mei-Ling Cheng, Min-Hui Liu, Li-Tang Kuo & Ming-Shi Shiao. (2017) Metabolic profile provides prognostic value better than galectin-3 in patients with heart failure. Journal of Cardiology 70:1, pages 92-98.
Crossref
Crossref
Qing Cao, Yang Shen, Xin Liu, Xin Yu, Ping Yuan, Rong Wan, Xiuxia Liu, Xiaogang Peng, Wenfeng He, Jielin Pu & Kui Hong. (2017) Phenotype and Functional Analyses in a Transgenic Mouse Model of Left Ventricular Noncompaction Caused by a <i>DTNA</i> Mutation. International Heart Journal 58:6, pages 939-947.
Crossref
Crossref
Gaoshu Zheng, Jiejie Cai, Xingxing Chen, Lingzhi Chen, Wenhua Ge, Xi Zhou & Hao Zhou. (2017) Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 40:7, pages 960-966.
Crossref
Crossref
Min-Hui Liu, Chao-Hung Wang, Ai-Fu Chiou, Ning-I Yang & Li-Tang Kuo. (2016) Factors Associated With Inadequate Effectiveness of a Multidisciplinary Disease Management Program in Heart Failure Patients Stratified by Galectin 3 Level. Biological Research For Nursing 19:1, pages 77-86.
Crossref
Crossref
Antonio Teixeira, Mattia Arrigo, Giuseppe Vergaro, Alain Cohen-Solal & Alexandre Mebazaa. (2017) Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients. Archives of Gerontology and Geriatrics 68, pages 33-38.
Crossref
Crossref
Henning Jansen, Wolfgang Koenig, Andrea Jaensch, Ute Mons, Lutz P Breitling, Hubert Scharnagl, Tatjana Stojakovic, Heribert Schunkert, Hermann Brenner & Dietrich Rothenbacher. (2016) Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study. Clinical Chemistry 62:10, pages 1372-1379.
Crossref
Crossref
Matt Varrier, Lui G Forni & Marlies Ostermann. (2015) Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes. Critical Care 19:1.
Crossref
Crossref
Varsha Srivatsan, Melvin George & Elangovan Shanmugam. (2014) Utility of galectin-3 as a prognostic biomarker in heart failure: where do we stand?. European Journal of Preventive Cardiology 22:9, pages 1096-1110.
Crossref
Crossref
Annika Jagodzinski, Aki S. Havulinna, Sebastian Appelbaum, Tanja Zeller, Pekka Jousilahti, Silke Skytte-Johanssen, Maria F. Hughes, Stefan Blankenberg & Veikko Salomaa. (2015) Predictive value of galectin-3 for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort. International Journal of Cardiology 192, pages 33-39.
Crossref
Crossref
Aditi Mallick & James L. JanuzziJr.Jr.. (2015) Biomarcadores en la insuficiencia cardiaca aguda. Revista Española de Cardiología 68:6, pages 514-525.
Crossref
Crossref
Aditi Mallick & James L. JanuzziJr.Jr.. (2015) Biomarkers in Acute Heart Failure. Revista Española de Cardiología (English Edition) 68:6, pages 514-525.
Crossref
Crossref
Mando D. Filipe, Wouter C. Meijers, A. Rogier van der Velde & Rudolf A. de Boer. (2015) Galectin-3 and heart failure: Prognosis, prediction & clinical utility. Clinica Chimica Acta 443, pages 48-56.
Crossref
Crossref
Aldo Clerico, Claudio Passino, Maria Franzini & Michele Emdin. (2015) Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. Clinica Chimica Acta 443, pages 17-24.
Crossref
Crossref
Peter A. McCullough & John L. Jefferies. (2015) Novel Markers and Therapies for Patients with Acute Heart Failure and Renal Dysfunction. The American Journal of Medicine 128:3, pages 312.e1-312.e22.
Crossref
Crossref
M. Varrier, L. G. Forni & M. Ostermann. 2015. Annual Update in Intensive Care and Emergency Medicine 2015. Annual Update in Intensive Care and Emergency Medicine 2015
391
402
.
Francisco Javier Carrasco-Sánchez & María Inmaculada Páez-Rubio. (2014) Review of the Prognostic Value of Galectin-3 in Heart Failure Focusing on Clinical Utility of Repeated Testing. Molecular Diagnosis & Therapy 18:6, pages 599-604.
Crossref
Crossref
Marwan F. Jumean & Michael S. Kiernan. (2014) Determinants of Survival Following Hospitalization for Acute Heart Failure. Current Heart Failure Reports 11:2, pages 201-211.
Crossref
Crossref
Daniela Schmitter, Gadi Cotter & Adriaan A. Voors. (2013) Clinical use of novel biomarkers in heart failure: towards personalized medicine. Heart Failure Reviews 19:3, pages 369-381.
Crossref
Crossref
George Karayannis, Filippos Triposkiadis, John Skoularigis, Panagiotis Georgoulias, Javed Butler & Gregory Giamouzis. (2013) The Emerging Role of Galectin-3 and ST2 in Heart Failure: Practical Considerations and Pitfalls Using Novel Biomarkers. Current Heart Failure Reports 10:4, pages 441-449.
Crossref
Crossref
Francisco Javier Carrasco-Sánchez, Oscar Aramburu-Bodas, Prado Salamanca-Bautista, José Luis Morales-Rull, Luis Galisteo-Almeda, María Inmaculada Páez-Rubio, José Luis Arias-Jiménez, Mariano Aguayo-Canela & Juan Ignacio Pérez-Calvo. (2013) Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. International Journal of Cardiology 169:3, pages 177-182.
Crossref
Crossref